Oncopeptides (Sweden) Price History
ONCO Stock | SEK 1.65 0.04 2.37% |
If you're considering investing in Oncopeptides Stock, it is important to understand the factors that can impact its price. As of today, the current price of Oncopeptides stands at 1.65, as last reported on the 1st of December, with the highest price reaching 1.75 and the lowest price hitting 1.59 during the day. Oncopeptides AB maintains Sharpe Ratio (i.e., Efficiency) of -0.0812, which implies the firm had a -0.0812% return per unit of risk over the last 3 months. Oncopeptides AB exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check Oncopeptides' Risk Adjusted Performance of (0.06), variance of 15.89, and Coefficient Of Variation of (1,115) to confirm the risk estimate we provide.
Oncopeptides Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Oncopeptides |
Sharpe Ratio = -0.0812
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | ||||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
Negative Returns | ONCO |
Estimated Market Risk
3.98 actual daily | 35 65% of assets are more volatile |
Expected Return
-0.32 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
-0.08 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Oncopeptides is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Oncopeptides by adding Oncopeptides to a well-diversified portfolio.
Oncopeptides Stock Price History Chart
There are several ways to analyze Oncopeptides Stock price data. The simplest method is using a basic Oncopeptides candlestick price chart, which shows Oncopeptides price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
Highest Price | September 12, 2024 | 2.31 |
Lowest Price | November 19, 2024 | 1.44 |
Oncopeptides December 1, 2024 Stock Price Synopsis
Various analyses of Oncopeptides' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Oncopeptides Stock. It can be used to describe the percentage change in the price of Oncopeptides from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Oncopeptides Stock.Oncopeptides Price Rate Of Daily Change | 0.98 | |
Oncopeptides Price Daily Balance Of Power | (0.25) | |
Oncopeptides Price Action Indicator | (0.04) |
Oncopeptides December 1, 2024 Stock Price Analysis
Oncopeptides Stock Price History Data
The price series of Oncopeptides for the period between Mon, Sep 2, 2024 and Sun, Dec 1, 2024 has a statistical range of 0.87 with a coefficient of variation of 13.41. The daily prices for the period are spread out with arithmetic mean of 1.98. The median price for the last 90 days is 2.1.Open | High | Low | Close | Volume | ||
12/01/2024 | 1.67 | 1.75 | 1.59 | 1.65 | ||
11/29/2024 | 1.67 | 1.75 | 1.59 | 1.65 | 649,426 | |
11/28/2024 | 1.71 | 1.75 | 1.60 | 1.69 | 960,861 | |
11/27/2024 | 1.50 | 1.77 | 1.50 | 1.66 | 1,955,642 | |
11/26/2024 | 1.52 | 1.52 | 1.49 | 1.51 | 311,048 | |
11/25/2024 | 1.51 | 1.55 | 1.49 | 1.50 | 387,006 | |
11/22/2024 | 1.54 | 1.57 | 1.49 | 1.54 | 309,114 | |
11/21/2024 | 1.59 | 1.59 | 1.49 | 1.51 | 258,428 | |
11/20/2024 | 1.47 | 1.61 | 1.47 | 1.49 | 820,214 | |
11/19/2024 | 1.45 | 1.48 | 1.43 | 1.44 | 501,930 | |
11/18/2024 | 1.48 | 1.50 | 1.43 | 1.45 | 574,510 | |
11/15/2024 | 1.51 | 1.51 | 1.45 | 1.48 | 460,252 | |
11/14/2024 | 1.50 | 1.54 | 1.48 | 1.51 | 406,630 | |
11/13/2024 | 1.54 | 1.57 | 1.50 | 1.50 | 341,836 | |
11/12/2024 | 1.55 | 1.55 | 1.51 | 1.54 | 428,643 | |
11/11/2024 | 1.53 | 1.59 | 1.50 | 1.55 | 969,145 | |
11/08/2024 | 1.61 | 1.70 | 1.49 | 1.53 | 2,003,387 | |
11/07/2024 | 1.90 | 1.90 | 1.51 | 1.60 | 4,043,509 | |
11/06/2024 | 2.09 | 2.13 | 2.06 | 2.08 | 464,700 | |
11/05/2024 | 2.10 | 2.15 | 2.07 | 2.08 | 154,356 | |
11/04/2024 | 2.12 | 2.15 | 2.08 | 2.10 | 340,239 | |
11/01/2024 | 2.11 | 2.12 | 2.07 | 2.09 | 34,763 | |
10/31/2024 | 2.12 | 2.15 | 2.09 | 2.09 | 245,342 | |
10/30/2024 | 2.16 | 2.17 | 2.13 | 2.13 | 116,541 | |
10/29/2024 | 2.13 | 2.17 | 2.10 | 2.14 | 304,549 | |
10/28/2024 | 2.17 | 2.19 | 2.14 | 2.14 | 206,440 | |
10/25/2024 | 2.01 | 2.17 | 2.01 | 2.17 | 356,346 | |
10/24/2024 | 2.04 | 2.09 | 2.03 | 2.09 | 265,370 | |
10/23/2024 | 2.04 | 2.10 | 2.04 | 2.09 | 224,397 | |
10/22/2024 | 2.09 | 2.10 | 2.04 | 2.06 | 257,291 | |
10/21/2024 | 2.10 | 2.10 | 2.05 | 2.09 | 250,686 | |
10/18/2024 | 2.10 | 2.11 | 2.05 | 2.09 | 347,131 | |
10/17/2024 | 2.09 | 2.13 | 2.06 | 2.10 | 124,927 | |
10/16/2024 | 2.09 | 2.10 | 2.05 | 2.10 | 322,919 | |
10/15/2024 | 2.09 | 2.13 | 2.08 | 2.09 | 141,316 | |
10/14/2024 | 2.12 | 2.14 | 2.07 | 2.09 | 123,228 | |
10/11/2024 | 2.12 | 2.17 | 2.10 | 2.12 | 208,830 | |
10/10/2024 | 2.13 | 2.15 | 2.09 | 2.12 | 156,405 | |
10/09/2024 | 2.11 | 2.17 | 2.10 | 2.13 | 145,873 | |
10/08/2024 | 2.15 | 2.18 | 2.11 | 2.11 | 196,898 | |
10/07/2024 | 2.15 | 2.19 | 2.13 | 2.15 | 374,028 | |
10/04/2024 | 2.19 | 2.20 | 2.11 | 2.13 | 388,208 | |
10/03/2024 | 2.14 | 2.19 | 2.06 | 2.19 | 584,236 | |
10/02/2024 | 2.14 | 2.15 | 2.10 | 2.14 | 230,072 | |
10/01/2024 | 2.13 | 2.15 | 2.10 | 2.12 | 419,721 | |
09/30/2024 | 2.17 | 2.19 | 2.09 | 2.15 | 382,177 | |
09/27/2024 | 2.23 | 2.23 | 2.15 | 2.17 | 345,719 | |
09/26/2024 | 2.17 | 2.22 | 2.12 | 2.19 | 519,980 | |
09/25/2024 | 2.13 | 2.19 | 2.09 | 2.17 | 509,852 | |
09/24/2024 | 2.13 | 2.13 | 2.09 | 2.09 | 368,759 | |
09/23/2024 | 2.17 | 2.19 | 2.09 | 2.13 | 617,364 | |
09/20/2024 | 2.13 | 2.26 | 2.13 | 2.17 | 607,540 | |
09/19/2024 | 2.12 | 2.18 | 2.10 | 2.13 | 695,455 | |
09/18/2024 | 2.16 | 2.16 | 2.09 | 2.09 | 276,731 | |
09/17/2024 | 2.19 | 2.19 | 2.11 | 2.17 | 537,057 | |
09/16/2024 | 2.22 | 2.23 | 2.08 | 2.11 | 803,007 | |
09/13/2024 | 2.33 | 2.34 | 2.15 | 2.19 | 1,731,591 | |
09/12/2024 | 2.05 | 2.74 | 2.05 | 2.31 | 9,769,892 | |
09/11/2024 | 2.11 | 2.11 | 2.04 | 2.07 | 678,713 | |
09/10/2024 | 2.14 | 2.19 | 2.05 | 2.10 | 404,688 | |
09/09/2024 | 2.13 | 2.15 | 2.05 | 2.14 | 288,573 |
About Oncopeptides Stock history
Oncopeptides investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Oncopeptides is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Oncopeptides AB will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Oncopeptides stock prices may prove useful in developing a viable investing in Oncopeptides
Oncopeptides AB , a pharmaceutical company, develops drugs for the treatment of cancer. The company was founded in 2000 and is headquartered in Stockholm, Sweden. Oncopeptides is traded on Stockholm Stock Exchange in Sweden.
Oncopeptides Stock Technical Analysis
Oncopeptides technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Headlines Timeline Now
Headlines TimelineStay connected to all market stories and filter out noise. Drill down to analyze hype elasticity |
All Next | Launch Module |
Oncopeptides Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Oncopeptides' price direction in advance. Along with the technical and fundamental analysis of Oncopeptides Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Oncopeptides to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Risk Adjusted Performance | (0.06) | |||
Jensen Alpha | (0.1) | |||
Total Risk Alpha | (1.03) | |||
Treynor Ratio | 0.1727 |
Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
Additional Tools for Oncopeptides Stock Analysis
When running Oncopeptides' price analysis, check to measure Oncopeptides' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Oncopeptides is operating at the current time. Most of Oncopeptides' value examination focuses on studying past and present price action to predict the probability of Oncopeptides' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Oncopeptides' price. Additionally, you may evaluate how the addition of Oncopeptides to your portfolios can decrease your overall portfolio volatility.